Human organic cation transporter 1 is expressed in lymphoma cells and increases susceptibility to irinotecan and paclitaxel.

MLA

Gupta, Shivangi, et al. “Human Organic Cation Transporter 1 Is Expressed in Lymphoma Cells and Increases Susceptibility to Irinotecan and Paclitaxel.” The Journal of Pharmacology and Experimental Therapeutics, vol. 341, no. 1, Apr. 2012, pp. 16–23. EBSCOhost, https://doi.org/10.1124/jpet.111.190561.

APA

Gupta, S., Wulf, G., Henjakovic, M., Koepsell, H., Burckhardt, G., & Hagos, Y. (2012). Human organic cation transporter 1 is expressed in lymphoma cells and increases susceptibility to irinotecan and paclitaxel. The Journal of Pharmacology and Experimental Therapeutics, 341(1), 16–23. https://doi.org/10.1124/jpet.111.190561

Chicago

Gupta, Shivangi, Gerald Wulf, Maja Henjakovic, Hermann Koepsell, Gerhard Burckhardt, and Yohannes Hagos. 2012. “Human Organic Cation Transporter 1 Is Expressed in Lymphoma Cells and Increases Susceptibility to Irinotecan and Paclitaxel.” The Journal of Pharmacology and Experimental Therapeutics 341 (1): 16–23. doi:10.1124/jpet.111.190561.